Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial - González Martín, Antonio; Desauw, Christophe; Heitz, Florian; Cropet, Claire; Gargiulo, Piera; Berger, Regina; Ochi, Hiroyuki; Vergote, Ignace; Colombo, Nicoletta; Mirza, Mansoor R.; Tazi, Youssef; Canzler, Ulrich; et al. (European journal of cancer, 2022)
Gesehen am 12.01.2023